TickerFactsScreenerDevelopers

Protalix BioTherapeutics, Inc. (PLX) — Cost of Revenue

Annual figures by fiscal year, from SEC filings.

2009: $3.58M2010: $4.38M2011: $1.52M2012: $8.14M2013: $02014: $630.0K2015: $730.0K2016: $8.40M2017: $15.23M2018: $9.30M2019: $10.89M2020: $10.87M2021: $16.35M2022: $19.59M2023: $22.98M2024: $24.32M2025: $26.99M$26.99M
2009Cost of Revenue (USD)2025
Fiscal YearCost of RevenueChange YoY
2025$26.99M+11.0%
2024$24.32M+5.8%
2023$22.98M+17.3%
2022$19.59M+19.8%
2021$16.35M+50.4%
2020$10.87M-0.2%
2019$10.89M+17.1%
2018$9.30M-38.9%
2017$15.23M+81.4%
2016$8.40M+1050.4%
2015$730.0K+15.9%
2014$630.0K—
2013$0-100.0%
2012$8.14M+434.0%
2011$1.52M-65.2%
2010$4.38M+22.6%
2009$3.58M—